Product
JZP541
1 clinical trial
1 indication
Indication
Autism Spectrum DisorderClinical trial
A Phase 2, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of JZP541 in Adults With Irritability Associated With Autism Spectrum DisorderStatus: Terminated, Estimated PCD: 2023-11-09